Dykan Jeff
- SEC CIK
- 0001661229
No open-market purchases or sales filed in the past year.
Current role at each company
- RGNT Regentis Biomaterials Ltd.Directoras of Jul 13, 2026
- LFWD Lifeward Ltd.Directoras of Sep 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dykan Jeff as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LFWD Lifeward Ltd.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing) | Nov 15 | 4 daysLate | Dykan JeffDirector | SSaleOrdinary Shares, par value NIS 0.25 per share | −4.13K | $1.53 | −$6.32K | −5.0%78.5K after | |
| Jun 30, 2022 (view filing) | Jun 7-8 | 23 days | Dykan JeffDirector | PPurchaseOrdinary Shares, par value NIS 0.25 per share | +25.0K | $1.02 | +$25.4K | +145.7%42.2K after | Amended2 lots |
| Aug 29, 2023 (view filing) | Aug 16-17 | 13 days | Dykan JeffDirector | PPurchaseOrdinary Shares, par value NIS 0.25 per share | +25.0K | $0.608 | +$15.2K | +100.0%50.0K after | Amended2 lots |